• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体靶向铂配合物通过涉及能量代谢的多种途径抑制肺癌。

Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism.

作者信息

Zhu Zhenzhu, Wang Zenghui, Zhang Changli, Wang Yanjun, Zhang Hongmei, Gan Zhenji, Guo Zijian, Wang Xiaoyong

机构信息

State Key Laboratory of Pharmaceutical Biotechnology , School of Life Sciences , Nanjing University , Nanjing , P. R. China . Email:

State Key Laboratory of Coordination Chemistry , School of Chemistry and Chemical Engineering , Nanjing University , Nanjing , P. R. China . Email:

出版信息

Chem Sci. 2019 Jan 22;10(10):3089-3095. doi: 10.1039/c8sc04871a. eCollection 2019 Mar 14.

DOI:10.1039/c8sc04871a
PMID:30996891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6428137/
Abstract

Mitochondria are potential therapeutic targets for anticancer drugs. A series of mitochondrion-targeted monofunctional platinum complexes, Pt(-PPhCHPy)(NH)Cl (OPT), Pt(-PPhCHPy)(NH)Cl (MPT), and Pt(-PPhCHPy)(NH)Cl (PPT) (PPh = triphenylphosphonium, Py = pyridine), are studied in this article. The antitumor activity and mechanism of action have been investigated and as well as on molecular levels. OPT exhibits higher efficacy than cisplatin against A549 lung cancer cells; furthermore, it shows a strong inhibition towards the growth of non-small-cell lung cancer in nude mice. The DNA binding ability of these complexes follows an order of PPT > OPT > MPT. Cellular uptake and distribution studies show that OPT accumulates mainly in mitochondria, while MPT and PPT accumulate more preferentially in nuclei than in mitochondria. As a result, OPT induces remarkable changes in the ultrastructure and membrane of mitochondria, leading to more radical mitochondrial dysfunctions than cisplatin. The release of cytochrome c from mitochondria is more evident for cells treated with OPT than with cisplatin, though the apoptosis of A549 cells induced by OPT is similar to that induced by cisplatin. Disruption to mitochondrial oxidative phosphorylation and glycolysis is involved in the antitumor mechanism of these compounds. The results indicate that in addition to DNA binding, bioenergetic pathways also play crucial roles in the antitumor activity of mitochondrion-targeted monofunctional platinum complexes.

摘要

线粒体是抗癌药物潜在的治疗靶点。本文研究了一系列线粒体靶向单功能铂配合物,即Pt(-PPhCHPy)(NH)Cl(OPT)、Pt(-PPhCHPy)(NH)Cl(MPT)和Pt(-PPhCHPy)(NH)Cl(PPT)(PPh = 三苯基鏻,Py = 吡啶)。研究了它们的抗肿瘤活性及其作用机制,包括在分子水平上的机制。OPT对A549肺癌细胞的疗效高于顺铂;此外,它对裸鼠非小细胞肺癌的生长有强烈抑制作用。这些配合物与DNA的结合能力顺序为PPT > OPT > MPT。细胞摄取和分布研究表明,OPT主要在线粒体中积累,而MPT和PPT在细胞核中的积累比在线粒体中更优先。结果,OPT引起线粒体超微结构和膜的显著变化,导致比顺铂更严重的线粒体功能障碍。与顺铂处理的细胞相比,OPT处理的细胞中线粒体细胞色素c的释放更明显,尽管OPT诱导的A549细胞凋亡与顺铂诱导的相似。线粒体氧化磷酸化和糖酵解的破坏参与了这些化合物的抗肿瘤机制。结果表明,除了与DNA结合外,生物能量途径在靶向线粒体的单功能铂配合物的抗肿瘤活性中也起着关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/ec0643442c2e/c8sc04871a-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/b57998ea747d/c8sc04871a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/284a9448e483/c8sc04871a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/d98d8d3e0601/c8sc04871a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/a24fcf5ccd7b/c8sc04871a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/7823e0d99b0f/c8sc04871a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/f9c972057835/c8sc04871a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/dc27e7c9b4f3/c8sc04871a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/ec0643442c2e/c8sc04871a-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/b57998ea747d/c8sc04871a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/284a9448e483/c8sc04871a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/d98d8d3e0601/c8sc04871a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/a24fcf5ccd7b/c8sc04871a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/7823e0d99b0f/c8sc04871a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/f9c972057835/c8sc04871a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/dc27e7c9b4f3/c8sc04871a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619e/6428137/ec0643442c2e/c8sc04871a-f8.jpg

相似文献

1
Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism.线粒体靶向铂配合物通过涉及能量代谢的多种途径抑制肺癌。
Chem Sci. 2019 Jan 22;10(10):3089-3095. doi: 10.1039/c8sc04871a. eCollection 2019 Mar 14.
2
DNA topoisomerases as additional targets for anticancer monofunctional platinum(ii) complexes.DNA 拓扑异构酶作为抗癌单功能铂(II)配合物的附加靶标。
Dalton Trans. 2021 Jan 7;50(1):304-310. doi: 10.1039/d0dt02608e. Epub 2020 Dec 10.
3
Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.线粒体靶向基团对铂(IV)配合物反应性和细胞抑制途径的影响。
Inorg Chem. 2018 Sep 4;57(17):11135-11145. doi: 10.1021/acs.inorgchem.8b01707. Epub 2018 Aug 17.
4
Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach.通过双 DNA 损伤途径增强单功能铂配合物的细胞毒性。
Inorg Chem. 2019 Oct 7;58(19):13150-13160. doi: 10.1021/acs.inorgchem.9b02033. Epub 2019 Sep 20.
5
The Influence of the Auxiliary Ligand in Monofunctional Pt(II) Anticancer Complexes on the DNA Backbone.单核 Pt(II)抗癌配合物中辅助配体对 DNA 骨架的影响。
Int J Mol Sci. 2024 Jun 13;25(12):6526. doi: 10.3390/ijms25126526.
6
Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.一类新型三取代铂(II)抗肿瘤药物的作用机制研究
Cancer Res. 1991 Apr 1;51(7):1866-75.
7
A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.一种基于 1,3,5-三嗪核心的新型星形三核铂(II)配合物,通过线粒体损伤和 DNA 损伤机制显示出对三阴性乳腺癌的强大抗增殖活性。
Dalton Trans. 2022 Jul 26;51(29):10930-10942. doi: 10.1039/d2dt00895e.
8
Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells.线粒体靶向铂(II)配合物通过内质网应激诱导 A549 癌细胞中凋亡依赖性自噬细胞死亡。
Eur J Med Chem. 2018 Jul 15;155:639-650. doi: 10.1016/j.ejmech.2018.06.018. Epub 2018 Jun 9.
9
A monofunctional platinum(II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition.一种源自水杨酰苯胺衍生物的单功能铂(II)基抗癌剂:合成、抗增殖活性及转录抑制
J Inorg Biochem. 2015 Jan;142:118-25. doi: 10.1016/j.jinorgbio.2014.10.003. Epub 2014 Oct 18.
10
Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line.通过甘氨酸甲酯和甲胺配体提高顺铂对人乳腺癌腺癌细胞系的抗癌活性和溶解性。
Appl Biochem Biotechnol. 2018 Oct;186(2):271-291. doi: 10.1007/s12010-018-2715-5. Epub 2018 Mar 8.

引用本文的文献

1
Photoactive monofunctional Pt(ii)-cyanine complex for nucleus and mitochondria dual-targeted antitumor therapy.用于细胞核和线粒体双靶向抗肿瘤治疗的光活性单功能铂(II)-菁配合物
Chem Sci. 2025 Jun 26. doi: 10.1039/d5sc01616a.
2
Silver(I) Ions Bridging Oxadiazole-2-thione Derivatives with Mitochondriotropic Agents: A Promising Strategy for Potent Anticancer Chemotherapy.银(I)离子桥连恶二唑-2-硫酮衍生物与线粒体靶向剂:一种有效的抗癌化疗的有前景策略。
Inorg Chem. 2025 Jul 7;64(26):13010-13029. doi: 10.1021/acs.inorgchem.5c01095. Epub 2025 Jun 23.
3
Carrier-Free Cisplatin-Dactolisib Nanoparticles for Enhanced Synergistic Antitumor Efficacy.

本文引用的文献

1
Stimuli-Responsive Therapeutic Metallodrugs.刺激响应型治疗金属药物
Chem Rev. 2019 Jan 23;119(2):1138-1192. doi: 10.1021/acs.chemrev.8b00209. Epub 2018 Oct 9.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.
用于增强协同抗肿瘤疗效的无载体顺铂-达可替尼纳米颗粒
ACS Biomater Sci Eng. 2025 Mar 10;11(3):1456-1471. doi: 10.1021/acsbiomaterials.4c00672. Epub 2025 Feb 24.
4
A PVP-stabilized cerium oxide-platinum nanocomposite synthesized in TEG: pro-/antioxidant activities.在三乙二醇中合成的聚乙烯吡咯烷酮稳定的氧化铈-铂纳米复合材料:促氧化/抗氧化活性
Nanoscale Adv. 2025 Jan 17;7(6):1686-1697. doi: 10.1039/d4na00857j. eCollection 2025 Mar 11.
5
Photodynamic therapy photosensitizers and photoactivated chemotherapeutics exhibit distinct bioenergetic profiles to impact ATP metabolism.光动力疗法光敏剂和光活化化疗药物表现出独特的生物能量特征以影响ATP代谢。
Chem Sci. 2024 Nov 21;16(2):721-734. doi: 10.1039/d4sc05393a. eCollection 2025 Jan 2.
6
Advances in Small-Molecule Fluorescent pH Probes for Monitoring Mitophagy.用于监测线粒体自噬的小分子荧光pH探针的研究进展
Chem Biomed Imaging. 2023 Aug 2;2(2):81-97. doi: 10.1021/cbmi.3c00070. eCollection 2024 Feb 26.
7
The Influence of the Auxiliary Ligand in Monofunctional Pt(II) Anticancer Complexes on the DNA Backbone.单核 Pt(II)抗癌配合物中辅助配体对 DNA 骨架的影响。
Int J Mol Sci. 2024 Jun 13;25(12):6526. doi: 10.3390/ijms25126526.
8
A G-quadruplex-binding platinum complex induces cancer mitochondrial dysfunction through dual-targeting mitochondrial and nuclear G4 enriched genome.一种结合 G-四链体的铂类复合物通过双重靶向富含 G4 的线粒体和核基因组诱导肿瘤线粒体功能障碍。
J Biomed Sci. 2024 May 13;31(1):50. doi: 10.1186/s12929-024-01041-6.
9
Recently Reported Biological Activities and Action Targets of Pt(II)- and Cu(II)-Based Complexes.近期报道的基于 Pt(II)和 Cu(II)的配合物的生物活性和作用靶点。
Molecules. 2024 Feb 29;29(5):1066. doi: 10.3390/molecules29051066.
10
Aerobic Exercise Improves Radiation Therapy Efficacy in Non-Small Cell Lung Cancer: Preclinical Study Using a Xenograft Mouse Model.有氧运动可提高非小细胞肺癌放射治疗效果:异种移植小鼠模型的临床前研究。
Int J Mol Sci. 2024 Feb 27;25(5):2757. doi: 10.3390/ijms25052757.
线粒体靶向基团对铂(IV)配合物反应性和细胞抑制途径的影响。
Inorg Chem. 2018 Sep 4;57(17):11135-11145. doi: 10.1021/acs.inorgchem.8b01707. Epub 2018 Aug 17.
4
A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer.一种用于研究非小细胞肺癌铂敏感性的诊断性微剂量给药方法。
Int J Cancer. 2017 Aug 1;141(3):604-613. doi: 10.1002/ijc.30747. Epub 2017 May 15.
5
Mitochondrial regulation of cell death: a phylogenetically conserved control.线粒体对细胞死亡的调控:一种系统发育保守的控制机制。
Microb Cell. 2016 Feb 23;3(3):101-108. doi: 10.15698/mic2016.03.483.
6
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.卡铂和培美曲塞联合或不联合帕博利珠单抗用于晚期非鳞状非小细胞肺癌:开放标签KEYNOTE-021研究的随机2期队列研究
Lancet Oncol. 2016 Nov;17(11):1497-1508. doi: 10.1016/S1470-2045(16)30498-3. Epub 2016 Oct 10.
7
Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.具有半乳糖胺归巢部分的双药负载纳米制剂用于肝脏靶向抗癌治疗。
Dalton Trans. 2016 Aug 16;45(33):13169-78. doi: 10.1039/c6dt01434h.
8
Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?非小细胞肺癌中 DNA 修复状态能否预测铂类治疗的反应?
Cancer Treat Rev. 2016 Jul;48:8-19. doi: 10.1016/j.ctrv.2016.05.004. Epub 2016 May 24.
9
Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy.癌症中的线粒体与线粒体活性氧:抗癌治疗的新靶点
J Cell Physiol. 2016 Dec;231(12):2570-81. doi: 10.1002/jcp.25349. Epub 2016 Jun 20.
10
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.下一代铂类药物:靶向铂(II)剂、纳米颗粒递送及铂(IV)前药
Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11.